| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ebacdf1be2792ff20a9060cb0257460
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0acc7fd312a68983fb8b9d120043467e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44 |
| filingDate |
2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd483281e07c8cfb560bd5a6bbc577bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a10112088060a751deeba7f0848b7093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46ea821e26c00f8bbb807d10ac9c9db0 |
| publicationDate |
2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019222636-A1 |
| titleOfInvention |
Methods and materials for identifying and treating cancer |
| abstract |
This document provides methods and materials involved in identifying and treating mammals having a cancer (e.g., a clear cell renal cell carcinoma (ccRCC)) based, at least in part on, 5-hydroxymethylcytosine (5hmC) levels. For example, methods and materials for administering a high dose of ascorbic acid (AA) with or without an additional chemotherapeutic agent to a mammal identified as having cancer having a reduced level of 5hmC are provided. Methods and materials for administering a chemotherapeutic agent without administering a high dose of AA to a mammal identified as having cancer exhibiting 5hmC expression also are provided. |
| priorityDate |
2018-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |